The FTSE 100 soars 5% on vaccine hopes. Is it time to buy these travel stocks?

The recent news of a potential Covid-19 vaccine has seen the FTSE soar. Is this now the perfect time to buy travel stocks?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Last week, I wrote an article about how the FTSE 100 was at its lowest level since March. Since I wrote this article, it has climbed nearly 12%. This has been due to both the ‘Biden bounce’, and news that Pfizer has developed a Covid-19 vaccine with a claimed 90% protection rate. This has caused a number of FTSE 100 stocks to climb rapidly, with a specific focus on travel stocks. But does this positive news make this the perfect time for me to buy these stocks?

This airline stock just soared 38%

After Rolls-Royce, IAG (LSE: IAG) was the largest riser in the FTSE 100 in Monday’s trading. Of course, the travel stock has been heavily affected by the pandemic, and its recent third-quarter trading update saw the company making an operating loss of €3.2bn. The recent imposition of further lockdowns in the UK and Europe has also been disastrous for the travel industry. This follows an incredibly hard summer brought about by the lack of tourism. As such, the British Airways owner has already had to raise £2.5bn in a rights issue to stay afloat. This resulted in share price lows of 66p (down from 260p at the start of the year).

Nevertheless, after the recent news of a potential effective vaccine, there is certainly far more optimism surrounding this stock. For example, it now seems possible a third wave can be avoided, and this could allow the airline owner to return to profitability next year. 

As a result, this particular travel stock now looks to me to be a far more appealing buy than it did a month ago. Although problems do still abound within the travel industry, and there’s uncertainty over when this potential vaccine would be available, I’d now be more tempted to buy IAG shares at some point. Even so, I do still believe that the market has reacted slightly too positively to the vaccine news. On the back of its 40% rise, I’d therefore expect a short-term decline and would wait a little longer before buying.  

This travel stock is a quality operator

National Express (LSE: NEX) is the other travel stock that particularly interests me. While the coach operator has had a dismal 2020, this follows consecutive years of growth, leading to good consumer relationships and strong liquidity. Contracts with local authorities have also allowed the company to offset some of its losses. As such, the recent vaccine news looks capable of propelling National Express shares back towards its former glory, as already shown by a 26% increase yesterday.   

Of course, similarly to IAG, the most recent lockdown will have had a severe effect on the coach operator. I’d therefore continue expecting short-term pain for the FTSE 250 stock. But in the long term, I remain optimistic, especially in the light of vaccine news. As such, I’d buy this stock. Once again, I wouldn’t rush into buying, but would wait, in expectation of the market correcting itself over the next few days.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Stuart Blair owns shares in National Express. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »